跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-TRIAZIDE TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
APO-TRIAZIDE TABLET
Approved
THERAPEUTIC
APO-TRIAZIDE TABLET
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Sep 11, 1991
Approval ID
cb0d6da14726d4fe
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
cb0d6da14726d4fe
Drug Name
APO-TRIAZIDE TABLET
Product Name
APO-TRIAZIDE TABLET
Approval Number
SIN06552P
Approval Date
1991-09-11
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C03EA01
Atc Item Name
hydrochlorothiazide and potassium-sparing agents
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
HYDROCHLOROTHIAZIDE
25 mg
TRIAMTERENE
50 mg
HYDROCHLOROTHIAZIDE
25 MG
TRIAMTERENE
50 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 11, 1991
Approval ID
cb0d6da14726d4fe
Type
Therapeutic
Back to HSA Approvals